Nuvectis Pharma, Inc. (NVCT) Tops Q3 EPS by 1c
Tweet
Share
E-mailGet Alerts NVCT Hot Sheet
Join SI Premium – FREE
Nuvectis Pharma, Inc. (NASDAQ: NVCT) reported Q3 EPS of ($0.24), $0.01 better than the analyst estimate of ($0.25).
For earnings history and earnings-related data on Nuvectis Pharma, Inc. (NVCT) click here.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- Nuvectis Pharma (NVCT) files $200M mixed shelf
- QSE closes $6M private placement with final tranche of $674K
- Cytek faces $56M damages award in Beckman Coulter patent case
Create E-mail Alert Related Categories
EarningsRelated Entities
Earnings, Maynard Um, Mark Zuckerberg, ARKSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
